CMRX Chimerix Inc.: Nilai Akuntansi saben Saham

Strong human capital and scientist motivation drive the development of Chimerix, Inc. (CMRX) in oncology. The expected book value per share smooths out market noise, and this metric has reached the level of 1.33. Government contracts for antiviral agents, integrated into a closed healthcare system, establish the financial foundation, creating a resilient biodefense and cancer therapy ecosystem.

CMRX - Nilai Buku Siji Saham Chimerix Inc. ing rentang 04.07.2022 - 26.04.2025

Ringkesan rincian data analitis chimerix.com (CMRX)

- rega lan prakiraan konsensus rega:

Bagan rega Chimerix, Inc|CMRX - Konsensus nilai wajar

- data kapitalisasi pasar:

Biji pasar Chimerix, Inc.|CMRX - Nilai Bisnis

- data kapitalisasi buku:

Nilai Buku saben Saham Chimerix|CMRX - Nilai Buku Bisnis|Rasio Kapitalisasi Pasar marang Nilai Buku chimerix.com|CMRX - Aset Perusahaan

- data utang lan likuiditas:

Utang marang Ekuitas Chimerix, Inc.|CMRX - Rasio utang jangka dawa marang modal|Utang jangka cendhak marang modal Chimerix|CMRX - Utang kumulatif perusahaan|Rasio utang marang kapitalisasi buku Chimerix, Inc.

Pambiji fundamental perusahaan:CMRX Chimerix, Inc

Chimerix, Inc. (CMRX) retains a staff of leading oncologists and virologists through long-term project financing and stock option programs. By analyzing the book value per share, an investor can see the residual value of net assets divided by the number of shares, which determines the business's actual safety cushion and its level of resilience to market volatility in the event of losses.

Pesaing Chimerix, Inc. (CMRX)